Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Efficacy, safety, and pharmacokinetics of alpelisib (ALP) in pediatric and adult patients with PIK3CA-related overgrowth spectrum (PROS): Epik-P4, a Phase II study

Alexandra J Borst, Denise M Adams, Juan C Lopez-Gutierrez, Friedrich Kapp, Ines Vendrell, Fotis Polydoros, Elise Burmeister-Getz, Nydia Caro, Guillaume Canaud

Blood (2025) 146 (Supplement 1): 8227.

https://doi.org/10.1182/blood-2025-8227

Published: 2025

Journal Articles

Epik-L1: A Phase 2/3 study of alpelisib in pediatric and adult patients with PIK3CA-driven lymphatic malformations

Bryan Sisk, Guillaume Canaud, Juan C Lopez-Gutierrez, Friedrich Kapp, Mario Stegert, Qinxia Wang, Elise Burmeister-Getz, Nydia Caro, Denise M Adams

Blood (2025) 146 (Supplement 1): 4893.

https://doi.org/10.1182/blood-2025-4893

Published: 2025

Journal Articles

Epik-P2: A Phase 2 Study of Alpelisib (ALP) in Pediatric and Adult Patients (pts) with PIK3CA -Related Overgrowth Spectrum (PROS)

Guillaume Canaud, Juan Carlos López-Gutiérrez, Adrienne M Hammill, Lisa Weibel, Séverine Niglis, Michaela Paul, Athanasia Papadimitriou, Monika Wroclawska, Denise M Adams

Blood (2024) 144 (Supplement 1): 5512.

https://doi.org/10.1182/blood-2024-198497

Published: 2024

Journal Articles

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia

Blood (2023) 141 (6): 634–644.

https://doi.org/10.1182/blood.2022016090

Published: 2023

Includes: Supplemental data

Journal Articles

Identification of a Novel Nucleoside Prodrug with Preferential Activity in Lymphoma and Leukemia Subtypes

Marissa L Calbert, Gurushankar Chandramouly, Tatiana Kent, Clare M Adams, Mrityunjay Tyagi, Yifan Wang, John Krais, Hoora Shaghaghi, Jessica Atkins, Tomasz Skorski, Neil Johnson, Christine M Eischen, Richard Pomerantz

Blood (2022) 140 (Supplement 1): 10701.

https://doi.org/10.1182/blood-2022-165514

Published: 2022

Journal Articles

Clonal hematopoiesis, myeloid disorders and BAX -mutated myelopoiesis in patients receiving venetoclax for CLL

Piers Blombery, Thomas E. Lew, Michael A. Dengler, Ella R. Thompson, Victor S. Lin, Xiangting Chen, Tamia Nguyen, Ashish Panigrahi, Sasanka M. Handunnetti, Dennis A. Carney, David A. Westerman, Constantine S. Tam, Jerry M. Adams, Andrew H. Wei, David C. S. Huang, John F. Seymour, Andrew W. Roberts, Mary Ann Anderson

Blood (2022) 139 (8): 1198–1207.

https://doi.org/10.1182/blood.2021012775

Published: 2022

Includes: Supplemental data

Journal Articles

Diagnostic Utility of Targeted Next Generation Sequencing in Patients with Vascular Anomalies

Whitney Eng, MD MPH, Sophie Dilek, BA, Abigail Ward, Harry PW Kozakewich, MD, Alyaa Al-Ibraheemi, MD, Katherine Janeway, MD MMSc, Denise M Adams, MD, Alanna Church, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-142873

Published: 2020

Journal Articles

Loss of the DNA Fork Remodeling Protein Smarcal1 Impairs the Replication Stress Response in Proliferating Hematopoietic Cells

Saul Kushinsky, BS, Matthew V Puccetti, MDPhD, Clare M Adams, PhD, Christine M Eischen, PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-140354

Published: 2020

Journal Articles

Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas

Amanda McBride, MD PhD, Clare M Adams, PhD, Ramkrishna Mitra, PhD, Christine M Eischen, PhD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-142545

Published: 2020

Journal Articles

An Elevated TRV Is Associated with Venous Thromboembolism in Sickle Cell Disease

Rachel M Adams, MD, Lianne S Kopel, MD, Demedrick Anton Bland, MD, Elizabeth S Klings, MD

Blood (2012) 120 (21): 3222.

https://doi.org/10.1182/blood.V120.21.3222.3222

Published: 2012

Journal Articles

Endogenous Bcl-x L is essential for Myc-driven lymphomagenesis in mice

Priscilla N. Kelly, Stephanie Grabow, Alex R. D. Delbridge, Andreas Strasser, Jerry M. Adams

Blood (2011) 118 (24): 6380–6386.

https://doi.org/10.1182/blood-2011-07-367672

Published: 2011

Includes: Supplemental data

Journal Articles

Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?

Hilary S. Gammill, Katherine A. Guthrie, Tessa M. Aydelotte, Kristina M. Adams Waldorf, J. Lee Nelson

Blood (2010) 116 (15): 2706–2712.

https://doi.org/10.1182/blood-2010-02-270942

Published: 2010

Journal Articles

Endogenous bcl-2 is not required for the development of Eμ- myc –induced B-cell lymphoma

Priscilla N. Kelly, Hamsa Puthalakath, Jerry M. Adams, Andreas Strasser

Blood (2007) 109 (11): 4907–4913.

https://doi.org/10.1182/blood-2006-10-051847

Published: 2007

Includes: Supplemental data

Journal Articles

Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death

Vanessa S. Marsden, Thomas Kaufmann, Lorraine A. O'Reilly, Jerry M. Adams, Andreas Strasser

Blood (2006) 107 (5): 1872–1877.

https://doi.org/10.1182/blood-2005-05-2160

Published: 2006

Includes: Supplemental data

Journal Articles

BH3-only proteins Puma and Bim are rate-limiting for γ-radiation– and glucocorticoid-induced apoptosis of lymphoid cells in vivo

Miriam Erlacher, Ewa M. Michalak, Priscilla N. Kelly, Verena Labi, Harald Niederegger, Leigh Coultas, Jerry M. Adams, Andreas Strasser, Andreas Villunger

Blood (2005) 106 (13): 4131–4138.

https://doi.org/10.1182/blood-2005-04-1595

Published: 2005

Includes: Supplemental data

Journal Articles

Targeting Lymphoid Malignancies with Small Molecule Inhibitors of Pro-Survival Bcl-2 Proteins.

Andrew W. Roberts, MBBS, PhD, Andrew Wei, MBBS, Mark F. van Delft, PhD, Kylie D. Mason, MBBS, Jerry M. Adams, PhD, David C.S. Huang, MBBS, PhD

Blood (2005) 106 (11): 1486.

https://doi.org/10.1182/blood.V106.11.1486.1486

Published: 2005

Journal Articles

Slug Antagonizes p53-Mediated Apoptosis of Hematopoietic Progenitors by Repressing Puma .

Wen-shu Wu, PhD, Stefan Heinrichs, PhD, Dong Xu, MD, Jerry M. Adams, MD, A. Thomas Look, MD

Blood (2005) 106 (11): 3624.

https://doi.org/10.1182/blood.V106.11.3624.3624

Published: 2005

Journal Articles

PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain

Wendy D. Cook, Benjamin J. McCaw, Christopher Herring, Deborah L. John, Simon J. Foote, Stephen L. Nutt, Jerry M. Adams

Blood (2004) 104 (12): 3437–3444.

https://doi.org/10.1182/blood-2004-06-2234

Published: 2004

Journal Articles

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation

Kristina M. Adams, Leona A. Holmberg, Wendy Leisenring, Alexander Fefer, Katherine A. Guthrie, Tracy S. Tylee, George B. McDonald, William I. Bensinger, J. Lee Nelson

Blood (2004) 104 (6): 1894–1897.

https://doi.org/10.1182/blood-2004-02-0508

Published: 2004

Journal Articles

Male DNA in female donor apheresis and CD34-enriched products

Kristina M. Adams, Nathalie C. Lambert, Shelly Heimfeld, Tracy S. Tylee, Jennifer M. Pang, Timothy D. Erickson, J. Lee Nelson

Blood (2003) 102 (10): 3845–3847.

https://doi.org/10.1182/blood-2003-05-1570

Published: 2003

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Efficacy, safety, and pharmacokinetics of alpelisib (ALP) in pediatric and adult patients with PIK3CA-related overgrowth spectrum (PROS): Epik-P4, a Phase II study

Epik-L1: A Phase 2/3 study of alpelisib in pediatric and adult patients with PIK3CA-driven lymphatic malformations

Epik-P2: A Phase 2 Study of Alpelisib (ALP) in Pediatric and Adult Patients (pts) with PIK3CA -Related Overgrowth Spectrum (PROS)

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia

Identification of a Novel Nucleoside Prodrug with Preferential Activity in Lymphoma and Leukemia Subtypes

Clonal hematopoiesis, myeloid disorders and BAX -mutated myelopoiesis in patients receiving venetoclax for CLL

Diagnostic Utility of Targeted Next Generation Sequencing in Patients with Vascular Anomalies

Loss of the DNA Fork Remodeling Protein Smarcal1 Impairs the Replication Stress Response in Proliferating Hematopoietic Cells

Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas

An Elevated TRV Is Associated with Venous Thromboembolism in Sickle Cell Disease

Endogenous Bcl-x L is essential for Myc-driven lymphomagenesis in mice

Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?

Endogenous bcl-2 is not required for the development of Eμ- myc –induced B-cell lymphoma

Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death

BH3-only proteins Puma and Bim are rate-limiting for γ-radiation– and glucocorticoid-induced apoptosis of lymphoid cells in vivo

Targeting Lymphoid Malignancies with Small Molecule Inhibitors of Pro-Survival Bcl-2 Proteins.

Slug Antagonizes p53-Mediated Apoptosis of Hematopoietic Progenitors by Repressing Puma .

PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation

Male DNA in female donor apheresis and CD34-enriched products

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only